<DOC>
	<DOCNO>NCT00133159</DOCNO>
	<brief_summary>Allergen-specific immunotherapy ( SIT ) , administration gradually increase quantity allergen extract allergic patient , curative approach directly treat underlie allergic disease . GrassMATAMPL develop provide pre-seasonal specific immunotherapy patient allergy grass pollen ( hay fever ) . The purpose double-blind Phase IIb study ass tolerability immunogenicity different dos GrassMATAMPL volunteer allergic grass rye pollen .</brief_summary>
	<brief_title>Different Doses Tyrosine Adsorbed Grass Pollen Allergoid With Monophosphoryl Lipid A ( MPL ) Patients Sensitized Grass Pollen</brief_title>
	<detailed_description />
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Hypersensitivity , Immediate</mesh_term>
	<mesh_term>Monophosphoryl lipid A</mesh_term>
	<criteria>positive skin prick test grass rye allergen Specific IgE grass rye document radioallergosorbent equivalent test class &gt; = 2 History least 1 season moderate severe seasonal rhinoconjunctivitis due IgE mediate allergy pollen grass rye Males nonpregnant , nonlactating female postmenopausal naturally surgically sterile . Females childbearing potential confirm absence pregnancy accord negative urine pregnancy test must use acceptable birth control method . Spirometry Screening demonstrates FEV1 &gt; = 80 % predict FEV1/FVC &gt; = 70 % Acute subacute atopic dermatitis and/or urticaria factitia and/or urticaria due physical chemical influence and/or chronic dermatitis Patient moderate severe asthma Visual inspection forearm indicate potential problem conduct interpretation skin prick test ; forearm must available test History presence diabetes , cancer clinically significant cardiac , metabolic renal , hematologic disease disorder Recent clinically significant history ( within 2 year ) hepatic gastrointestinal , dermatologic , venereal , neurologic psychiatric disease disorder Any clinically significant ( determined investigator ) abnormal laboratory value Perennial allergens : clinically relevant sensitivity house dust mite , mold , epithelium Patient clinically relevant sensitivity follow summer/autumn season flower plant : plantain , orache , nettle , mugwort , Bermuda grass , ragweed . Secondary alteration affect organ History autoimmune disease and/or rheumatoid disease Patient take bblockers Patient allow receive adrenalin Patients tyrosine metabolism disturb Presence disease pathogenesis interfere immune response patient receive medication could influence result study Documented evidence acute significant chronic infection History anaphylaxis Documented history angioedema Hypersensitivity excipients study medication Previous current immunotherapy comparable grass/rye allergen extract Currently use antiallergy medication drug antihistaminic activity Patients currently participate clinical trial expose study medication within last 30 day Patient pregnant planning pregnancy and/or lactate Patient receive treatment preparation contain MPLÂ® past 12 month Any systemic disorder could interfere evaluation study medication ( ) Clinical history drug alcohol abuse would interfere patient 's participation study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>Allergy</keyword>
	<keyword>Specific Immunotherapy</keyword>
</DOC>